tOTX015
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for tOTX015, covering 2016-09-01 to 2016-09-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study Assessing tOTX015 in Combination With Azacitidine (AZA) or AZA Single Agent in Patients With Newly-diagnosed Acute Myeloid Leukemia (AML) Not Candidate for Standard Intensive Induction Therapy (SIIT) [Phase 1, Phase 2]